GreA is a well-characterized transcriptional factor that acts primarily by rescuing stalled RNA polymerase complexes, but has also been shown to be the major transcriptional fidelity and proofreading factor, while it inhibits DNA break repair. Regulation of greA gene expression itself is still not well understood. So far, it has been shown that its expression is driven by two overlapping promoters and that greA leader encodes a small RNA (GraL) that is acting in trans on nudE mRNA. It has been also shown that GreA autoinhibits its own expression in vivo. Here, we decided to investigate the inner workings of this autoregulatory loop. Transcriptional fusions with lacZ reporter carrying different modifications (made both to the greA promoter and leader regions) were made to pinpoint the sequences responsible for this autoregulation, while GraL levels were also monitored. Our data indicate that GreA mediated regulation of its own gene expression is dependent on GraL acting in cis (a rare example of dual-action sRNA), rather than on the promoter region. However, a yet unidentified, additional factor seems to participate in this regulation as well. Overall, the GreA/GraL regulatory loop seems to have unique but hard to classify properties.
Introduction
Gene expression regulation can take place at several levels, e.g., at the transcriptional, post-transcriptional, and translational level. In bacteria, transcriptional regulation usually occurs at the stage of initiation, i.e., activators or repressors bind to a specific promoter region sequence, and enhance or inhibit transcription, respectively. Transcription could also be regulated at the stage of elongation (e.g., by the Escherichia coli GreA and GreB proteins that directly interact with RNA polymerase (RNAP), see below), or at the stage of termination (e.g., by antitermination factors, such as the Nus factors (NusA, NusB, NusG and NusE), which form a complex interaction with both RNAP and specific RNA sequences [1] ). Other examples include attenuation mediated by ribosomes or regulation by RNA aptamers bound to RNAP [2] [3] [4] .
A large group of transcriptional regulators also includes small RNA (sRNA). These short RNA species, ranging in size from 50 to 500 nucleotides (nt) [5] , were shown to either act in cis (e.g., antisense RNAs [5] and riboswitches [3] ) or in trans, where they enhance or inhibit translation of their targets by diverse mechanisms, relying on complementary base-pairing [6] . Trans acting sRNAs often require a protein chaperone mediating sRNA-target mRNA interaction, called Hfq [5] . Here, we decided to dissect the mechanism of GreA mediated inhibition of greA gene expression in vivo by investigating at which stage of transcription this regulation takes place and whether GraL plays any in cis role in this process. We found that GreA autoregulation is promoter region independent, Here, we decided to dissect the mechanism of GreA mediated inhibition of greA gene expression in vivo by investigating at which stage of transcription this regulation takes place and whether GraL plays any in cis role in this process. We found that GreA autoregulation is promoter region independent, while it relies on the GraL sequence, both upstream of the terminator and forming the terminator hairpin. Thus, GraL is not only an unusual example of imprecise termination but it also seems to represent a new paradigm of an sRNA acting both in cis and in trans. Moreover, feedback inhibition by GreA in vivo is nearly completely abolished by a mutation that eliminates the ability of GreA to cleave backtracked nascent RNA. Although many questions still remain, our data furthers the understanding of how gene expression of the GreA global transcriptional regulator is controlled.
Results

GreA Autoregulation Depends on Catalytically Active GreA
In the first step of our investigation, we wanted to explore whether the previously observed inhibition of greA expression by GreA depends on the GreA's antipausing activity and ability to induce the intrinsic endonucleolytic activity of RNAP. For this purpose, we used a GreA D41A mutant that has been shown to completely lose its antipause effect on RNAP activity but that is still able to bind to the RNAP secondary channel [12] . A region spanning from −1030 to +175 of greA (where +1 corresponds to the transcription initiation site of the greA P1 promoter) was fused to the lacZ reporter gene and introduced onto the chromosome in a single copy. β-galactosidase activity was monitored in wild-type (∆lacZ) and corresponding ∆greA cells, bearing either a vector control (pBR322), a plasmid encoding wild-type (wt) GreA (pBR-GreA), or its catalytically inactive counterpart (pBR-GreAD41A), cloned under its native promoters.
As shown in Figure 2 and reported previously [25] , in the absence of GreA, transcriptional activity of the pgreA-lacZ fusion is significantly increased (about 3.5-fold). Reintroduction of native GreA complemented the ∆greA strain in respect to bringing back the fusion's β-galactosidase activity to the wt levels. Importantly, under the same conditions, the GreA D41A mutant was unable to repress greA expression, implying not only that the mechanism of GreA autoregulation involves transcription but also that this mechanism is likely to require cleavage of backtracked RNA. This also suggests that GreA autoregulation might take place at a stage other than transcriptional initiation since a double GreA mutant [D41A E44A] was previously shown to retain its regulation at this step of transcription in case of another promoter in vivo [18] .
GreA Autoregulation is Independent of the Promoter Region
To verify in another way that GreA autoregulation is independent of the transcription initiation step, several single-copy transcriptional fusions with the lacZ reporter gene were constructed, methodically changing the promoter region elements (Figure 3 , left panels). The basic fusion contained a greA region spanning −100 to +136 bp, where +1 again corresponds to the P1 promoter transcription initiation site (pgreA all -lacZ). The greA promoter region (−1 to −36) was then replaced by the plac UV5 promoter, while other elements were retained (plac UV5 -greA-lacZ fusion). In another construct, the region upstream of the promoter was replaced by the plac UP region in addition to the promoter replacement (UP-plac UV5 -greA-lacZ fusion). In addition, the CRP (catabolite repressor protein) binding site was mutated so as to abolish any possible effects of catabolite repression that regulates plac expression. The changes were at positions −66 (G->A) and −55 (C->T) [27] . Since the P1 and P2 promoters are overlapping, all of the fusions retained part of the −10 sequence of P2; removing it would alter the GraL sequence. Therefore, as control, a similar transcriptional fusion to UP-plac UV5 -greA-lacZ but bearing only the first 10 nt of the greA leader was also constructed, to exclude the possibility that the P2 promoter still remained active and was prone to GreA regulation (UP-plac UV5 -greA+10-lacZ). Importantly, all constructs lack the plac operator region and thus are not under LacI control. The constructs were introduced in a single copy on the chromosome of a ∆lacZ strain (CF15617), and their activity was assessed by β-galactosidase activity assays in the presence or absence of GreA, overproduced from a low copy plasmid (a pGB2 derivative) under an inducible ptac promoter (pHM1873, called here pGreA; this plasmid does not encode GraL). pHM1883 served as the vector control (pV).
The results are presented in Figure 3 (middle and right panels). It is clear that GreA-mediated inhibition occurs in all three cases where GraL and its downstream region are present ( Figure 3a-d) , regardless of the promoter region present. The extent of inhibition depends on the presence of isopropyl-β-D-thio-galactopyranoside (IPTG)-only a minor effect is observed when compared to full downregulation that occurs upon 1 mM IPTG addition (at OD 600~0 .5-, 1.0-and 2.0, the fold repression by GreA was calculated to be -for pgreA all -lacZ: 2.5-, 3.7-, and 4.9-fold when compared to the pV+IPTG strain (no IPTG: 1.2, 1.1, and 1.2, when compared to the pV strain); for plac UV5 -greA-lacZ fusion: 2.2-, 3.8-and 4.3-fold (no IPTG: 1.1, 1.2, and 1.6); and for UP-plac UV5 -greA-lacZ: 2.2-, 2.3-, and 2.8-fold (no IPTG: 1.5, 1.4, and 1.4)). This is probably due to the fact that native greA was also present on the chromosome and thus overproduction was needed to observe a substantial effect. It should be noted though that addition of IPTG also had a minor effect on the pV strains.
The only fusion that remained largely unaffected was the control bearing only the +10 greA leader region (similar β-galactosidase activities for strains bearing pGreA and pV in the presence of IPTG). Altogether, these data independently verify that GreA regulation of greA expression is independent of the promoter region but does depend on the greA leader. 
To verify in another way that GreA autoregulation is independent of the transcription initiation step, several single-copy transcriptional fusions with the lacZ reporter gene were constructed, methodically changing the promoter region elements (Figure 3 , left panels). The basic fusion contained a greA region spanning −100 to +136 bp, where +1 again corresponds to the P1 promoter transcription initiation site (pgreAall-lacZ). The greA promoter region (−1 to −36) was then replaced by the placUV5 promoter, while other elements were retained (placUV5-greA-lacZ fusion). In another construct, the region upstream of the promoter was replaced by the plac UP region in addition to the promoter replacement (UP-placUV5-greA-lacZ fusion). In addition, the CRP (catabolite repressor protein) binding site was mutated so as to abolish any possible effects of catabolite repression that regulates plac expression. The changes were at positions −66 (G->A) and −55 (C->T) [27] . Since the P1 and P2 promoters are overlapping, all of the fusions retained part of the −10 sequence of P2; removing it would alter the GraL sequence. Therefore, as control, a similar transcriptional fusion to UP-placUV5-
Catalytically active GreA is required for GreA autoregulation. Transcrip tional activity of the greA promoter and leader region (−1030 to +175) was measured by monitoring β-galactosiadase activity of the pgreA-lacZ fusion in different strain backgrounds: wt-wild type (LFC3-MG1655 ∆lacZ [17] ), ∆greA (LFC4-MG1655 ∆lacZ ∆greA); pBR-322-vector control; pBR-GreA-vector bearing greA gene under its native promoter region (i.e., GraL was present as well); pBR-GreAD41-the same as pBR-GreA but encoding catalytically inactive GreA. Cells were grown at 37 • C in LB (Luria Broth) with aeration; at OD 600~1 .5 samples were removed and β-galactosidase activity was measured. Average results from three independent experiments are shown. Error bars represent S.D. For clarity, p-values calculated for wt pBR322 vs. ∆greA strains are only shown. *** p < 0.0005. Figure 3 . The promoter region does not determine autoregulation exerted by GreA. Assessment of βgalactosidase activity in strains overproducing GreA from a multicopy plasmid (pGreA) for: (a) pgreAall-lacZ; (b) placUV5-greA-lacZ; (c) UP-placUV5-greA-lacZ; (d) UP-placUV5-greA+10-lacZ (negative control) fusions. Wt ΔlacZ strains carrying appropriate single copy fusions were grown in LB at 32 °C with aeration; if present, isopropyl-β-D-thio-galactopyranoside (IPTG) was added at OD600 ~ 0.1 to 1 mM; pV-vector control. Left panels-schematic representation of the lacZ fusions employed; hairpin symbolizes the GraL terminator; not drawn to scale. Middle panels-differential plots of βgalactosidase activities vs. OD600, following transcriptional activity throughout growth. The slope of each curve corresponds to the specific activity of β-galactosidase. Right panels-specific βgalactosidase activities assessed for each strain at OD600 ~ 0.5, 1.0, and 2.0 (experiment was done in triplicate). Error bars represent S.D. For clarity, p-values calculated for pV vs. pGreA, and pV+IPTG vs. pGreA+IPTG are only shown. * p < 0.05, ** p < 0.005, *** p < 0.0005. Wt ∆lacZ strains carrying appropriate single copy fusions were grown in LB at 32 • C with aeration; if present, isopropyl-β-d-thio-galactopyranoside (IPTG) was added at OD 600~0 .1 to 1 mM; pV-vector control. Left panels-schematic representation of the lacZ fusions employed; hairpin symbolizes the GraL terminator; not drawn to scale. Middle panels-differential plots of β-galactosidase activities vs. OD 600 , following transcriptional activity throughout growth. The slope of each curve corresponds to the specific activity of β-galactosidase. Right panels-specific β-galactosidase activities assessed for each strain at OD 600~0 .5, 1.0, and 2.0 (experiment was done in triplicate). Error bars represent S.D. For clarity, p-values calculated for pV vs. pGreA, and pV+IPTG vs. pGreA+IPTG are only shown. * p < 0.05, ** p < 0.005, *** p < 0.0005.
The Amount of GraL Produced Depends on the GreA Level in the Cell
Next, we investigated whether the observed GreA-mediated transcriptional inhibition might be due to an increased production of GraL encoded in the greA leader region. As mentioned above, GraL terminates~2/3 of transcripts that initiate in the pgreA P1P2 promoter region, allowing only~1/3 of transcripts to extend into full greA mRNA. We reasoned that increased transcriptional termination at the GraL terminator would thus yield less full-length transcripts and cause a decrease in the observed β-galactosidase activity of the employed fusions.
First, we wanted to establish whether the GraL level is constant throughout the bacterial growth cycle or if it changes. Therefore, GraL levels were monitored by Norther blot analysis, employing the E. coli ∆lacZ strain (CF15617). As shown in Figure 4 , the GraL level is rather constant in the log phase; however, it increases in the stationary phase by 1.8-fold at the highest OD 600 tested, i.e., 3.0, when compared to the GraL level at OD 600 = 0.1. addition of IPTG also had a minor effect on the pV strains.
The only fusion that remained largely unaffected was the control bearing only the +10 greA leader region (similar β-galactosidase activities for strains bearing pGreA and pV in the presence of IPTG). Altogether, these data independently verify that GreA regulation of greA expression is independent of the promoter region but does depend on the greA leader.
Next, we investigated whether the observed GreA-mediated transcriptional inhibition might be due to an increased production of GraL encoded in the greA leader region. As mentioned above, GraL terminates ~2/3 of transcripts that initiate in the pgreA P1P2 promoter region, allowing only ~1/3 of transcripts to extend into full greA mRNA. We reasoned that increased transcriptional termination at the GraL terminator would thus yield less full-length transcripts and cause a decrease in the observed β-galactosidase activity of the employed fusions.
First, we wanted to establish whether the GraL level is constant throughout the bacterial growth cycle or if it changes. Therefore, GraL levels were monitored by Norther blot analysis, employing the E. coli ΔlacZ strain (CF15617). As shown in Figure 4 , the GraL level is rather constant in the log phase; however, it increases in the stationary phase by 1.8-fold at the highest OD600 tested, i.e., 3.0, when compared to the GraL level at OD600 = 0.1. We next asked if the amount of GreA affects GraL abundance. Therefore, we measured the level of GraL produced in the wild type ∆lacZ and ∆greA ∆lacZ strains in the presence of pGreA or the control plasmid (pV). As demonstrated in Figure 5a , induction of GreA overexpression in wt/pGreA cells by adding 1 mM IPTG moderately increased the GraL level (a~1.25-fold increase) when compared to IPTG untreated cells or cells carrying vector control, although this increase is not statistically significant. In contrast, in the ∆greA strains carrying pV, the GraL level decreased~4-fold when compared to the wild type strain. When pGreA plasmid was now introduced, in the absence of IPTG, the GraL level has increased~4-fold, almost reaching the level present in the wt/pV cells. When IPTG was added to 1 mM to further induce GreA overexpression, the GraL level in these cells reached the level present in the wt/pA + IPTG cells. These results strongly suggest that increasing the GreA level indeed has a positive effect on GraL production. when compared to the wild type strain. When pGreA plasmid was now introduced, in the absence of IPTG, the GraL level has increased ~4-fold, almost reaching the level present in the wt/pV cells. When IPTG was added to 1 mM to further induce GreA overexpression, the GraL level in these cells reached the level present in the wt/pA + IPTG cells. These results strongly suggest that increasing the GreA level indeed has a positive effect on GraL production. Figure 4 . If present, IPTG was added to 1 mM at OD 600~0 .1. Samples were taken from wt or ∆greA strains at OD 600~3 .0. Data were normalized to wt/pV; this experiment was done in triplicate. (b) Same as in (a) but with the ∆lacZ ∆greA ∆GraL strain carrying the UPlac-plac UV5 -greA-lacZ fusion; data were normalized to the pGreA sample; experiment was done in triplicate. (c) A representative differential plot of β-galactosidase activities of the strain used in (b). Next, we wanted to verify that the observed changes in GraL abundance correlate with our previous observations made with promoter region replacement fusions. The single copy UPlac-plac UV5 -greA-lacZ fusion was chosen for these studies. However, this time, the strain was deleted for greA and GraL on the chromosome (ECMZ1604). In this setting, GraL originates only from the fusion construct under investigation. Figure 5b displays the GraL levels assessed by Northern blot analysis, whereas Figure 5c ,d shows β-galactosidase reporter activity of the fusion corresponding to the full-length transcripts that were able to proceed through the GraL terminator and yield lacZ mRNA. It is evident that high GraL levels in the strain carrying pGreA plasmid correlate with decreased β-galactosidase activity of the tested fusion.
The Observed GreA Inhibition of greA Expression is not Due to GraL Acting in trans on its Own mRNA
Next, we wanted to investigate a possibility that GraL acting in trans, instead of GreA, enhances termination at the GraL terminator and thus increases GraL production. Therefore, similar experiments to those presented in Figure 3 were performed, where β-galactosidase activity of different lacZ fusions was monitored, but this time GraL (and not GreA) overproduction was induced from a low copy plasmid. No major differences in the activity of the fusions were noted, either in the wt or ∆greA ∆GraL background ( Figure S1 and Table S1 ).
In addition, since sRNAs acting in trans often require Hfq protein for binding to their mRNA targets [5] , β-galactosidase activity of the investigated fusions was also monitored in strains either overproducing Hfq or carrying an hfq deletion (again, GreA levels were not altered). The only substantial difference was observed for the ∆hfq strain carrying the pgreAall-lacZ fusion, whose activity decreased about 1.5-fold in comparison to the wt strain throughout growth ( Figure S2 and Table S2 ). This could imply that another sRNA could perhaps regulate greA transcription at the promoter (either directly or indirectly through another target), but GreA regulation is not involved in this step. When GreA overproduction was induced from the pGreA plasmid in ∆hfq strains, similar behavior to that reported in Figure 3 was observed for all fusions ( Figure S3 and Table S3 ). We take this to mean that GreA autoregulation does not require Hfq.
GreA Mediated Regulation Requires Cis-Acting Gral Sequences in Addition to the Terminator Structure
The results obtained thus far seem to point to the in cis role of GraL. Alternatively, it could be that not the GraL sequence per se, but rather only the terminator structure participates in the GreA autoregulation, as our previous investigation had hinted that the terminator hairpin might be involved in this process [25] . To answer this question, another set of transcriptional fusions with the lacZ reporter gene were constructed ( Figure 6, left panels) .
First, the initial GraL sequence (+1 to +18) that does not include the terminator hairpin was randomly scrambled, preserving the GC (guanosine and cytosine) content (GraL-Scr-lacZ fusion). In this case, GreA overproduction from the pGreA plasmid still represses the full-length transcript formation as judged from β-galactosidase reporter activities, although to a much lesser degree (1.2-, 1.4-and 1.7-fold repression at OD 600 = 0.5, 1.0, and 2.0, respectively, vs. 2.5, 3.7-, and 4.9-fold inhibition at the respective OD's for the wt fusion, comparing Figure 6a with Figure 3a ). Second, we switched the sequences of the terminator hairpin arms (region spanning +19 to +48) which retained base pairings to preserve the terminator's secondary structure (Ter-Scr-lacZ fusion, Figure 6b ). This resulted in similarly abolished GreA mediated repression in the logarithmic phase of growth, with only some inhibition in the late stationary phase (1.0-, 1.0-, and 1.5-fold inhibition at OD 600 = 0.5, 1.0, and 2.0, respectively). Third, a construct combining both modifications was employed (+1 to +18 scrambled and +19 to +48 region switched; All-Scr-lacZ fusion, Figure 6c ), and yielded similar results (0.9-, 1.0-, and 1.5-fold repression at OD 600 = 0.5, 1.0, and 2.0, respectively). In order to make sure that the scrambled sequences were still functional in termination, in vitro transcription reactions were carried out with these templates and confirmed that indeed termination at the modified sequences still takes place ( Figure S4) .
Finally, to determine if the sequence downstream of the terminator hairpin might be important for GreA autoregulation, as it may possibly pair with GraL, a fusion devoid of the sequence downstream of the U-rich tail after the terminator was constructed (the region immediately downstream of +59 was deleted; "no downstream sequence": NDS-lacZ). As evidenced in Figure 6d , the downstream sequence does not contribute to GreA autoregulation, since the β-galactosidase reporter activities were similar to those of the wt fusion (2.8-, 3.9-, and 8.4-fold inhibition at OD 600 = 0.5, 1.0, and 2.0, respectively; compare Figure 6d with Figure 3a) . Wt ∆lacZ (CF15617) strains carrying appropriate single copy fusions were grown in LB at 32 • C with aeration; if present, IPTG was added at OD 600~0 .1 to 1 mM; pV-vector control. Left panels-schematic representation of the lacZ fusions employed; hairpin symbolizes the GraL terminator; not drawn to scale. Middle panels-differential plots of β-galactosidase activities vs. OD 600 , following transcriptional activity throughout growth. The slope of each curve corresponds to the specific activity of β-galactosidase. Right panels-specific β-galactosidase activities assessed for each strain at OD 600~0 .5, 1.0, and 1.5 (experiment was done in triplicate). Error bars represent S.D. For clarity, p-values calculated for pV vs. pGreA, and pV+IPTG vs. pGreA+IPTG are only shown. * p < 0.05, ** p < 0.005, *** p < 0.0005. All of the above data indicated that it is not only the terminator structure of GraL, but also its sequence (both upstream of the terminator and participating in the terminator formation) that are important for GreA autoregulation. Thus, GraL acting in cis is necessary for GreA autoregulation to occur.
None of the Nus Factors nor σ E Affect greA Regulation
Next, we wanted to assess whether Nus factors would have any effect on the GraL terminator read-through since they are known to affect transcriptional elongation, as well as termination and antitermination efficiency [1, 28] . The four lacZ fusions with promoter region replacements shown in Figure 3a were tested in the absence or presence of plasmids carrying nusA, nusB, nusE, or nusG under an IPTG inducible ptac promoter. Wt ∆lacZ (CF15617) strains were used, expressing greA from the chromosome. No substantial effect was observed when any of the Nus factors were overproduced ( Figure S5 and Table S4 ).
We also tested whether σ E induction would have any effect on the four lacZ fusions tested, since the greA P2 promoter is σ E dependent. We reasoned that GraL termination efficiency might also be under σ E control, since it has been recently suggested that factors inducing a given sRNA transcription often also affect termination at their respective intrinsic terminators [29] . Here, in order to induce σ E , we used a pBAI66 plasmid overexpressing a misfolded peptide that accumulates in the periplasm [30] . Again, wt ∆lacZ (CF15617) strains were used as hosts. Our data indicated that the pgreA all -lacZ fusion is only moderately responsive to σ E ; however, we observed no differences in β-galactosidase activity for the other three constructs ( Figure S6 and Table S5 ).
Discussion
In the study presented here, we turned to GreA, a global transcriptional regulator, shown to have many positive effects, such as rescuing stalled RNAP complexes and being responsible for proofreading and transcriptional fidelity [9, 21, 22] . GreA has been also shown to negatively influence the DNA break repair process [31] . It was also shown to influence gene expression of about 190 genes, when overproduced in E. coli (assuming significant changes in expression are at a log level of 0.5 [32] ). On the other hand, competition between GreA and other factors that bind to the RNAP secondary channel is predicted to be perturbed when GreA levels change markedly [18] . One can thus imagine that there is a need for greA expression to be fine-tuned and tightly regulated.
In our earlier work, we showed that greA leader encodes a small RNA (GraL) and that GreA autoregulates its own gene expression [25] . Here, we demonstrate that this autoregulation depends on GraL acting in cis, i.e., the GraL sequence is necessary and sufficient for the full GreA-mediated repression to occur. Interestingly, the sequence upstream of the terminator is important, as well as the terminator hairpin sequence itself. The promoter region does not seem to play a major part here, indicating that GreA does not affect the transcription initiation step. In addition, catalytically active GreA is required for the autoregulation to take place. One prospect of future research may include investigation of GraL placement in the leader structure, to see if placing it further from the promoters would have any effect on autoregulation.
It has been suggested recently that the genes downstream of the sRNA's terminators are expressed discordantly from the sRNAs encoded in their 5 UTR regions [29] . Given the results described above, this seems not to be the case for GraL and greA. In this instance, GreA levels tightly regulate GraL abundance, and GraL acts in cis to determine the resulting GreA levels. It is not surprising that such a tight regulatory circuit exists since, as mentioned above, GreA is an important transcription regulator and its levels remain fairly constant throughout growth, being slightly higher in the exponential phase of growth than in the stationary phase [33] . What is surprising in this context is that GraL is also acting in trans, with nudE (encoding a nudix-type hydrolase) being the most likely target [26] . This implies that the GreA regulatory web is even more widespread than previously appreciated. In addition, microarray experiments showed that GraL affects more than 100 genes when overproduced, and it was demonstrated that the presence of GraL enhances cellular fitness as well [25] . In addition, another screen revealed about 40 synthetic lethal genes with GraL, representing diverse functions [26] .
GraL acting both in cis and in trans is a rare example of a dual action sRNA. To our knowledge, there is only one other well-documented example of this type-SreA riboswitch from Listeria monocytogenes [34] , and one report implying such a possibility for Brt1 sRNA from Bartonella hensenae [35] . It is possible that such a dual mechanism of action might be more common than previously thought and more examples await detailed studies.
The simplest model of GreA autoregulation could be imagined to feature catalytically-active GreA as a factor inducing termination at the GraL terminator and thus regulating read-through of the full-length greA mRNA. However, it is intriguing that GreA autoregulation has been only observed so far in vivo and not in vitro ( [25] ; and Figure S4 ). This implies that GreA either requires an accessory factor to induce termination (direct mode of GreA autoregulation), or GreA is regulating expression of another factor that in turn regulates GraL termination (indirect mode of GreA autoregulation). Arguments can be made in favor of each model. The involvement of GreA antipause activity ( Figure 2 ) can be seen as evidence of indirect regulation, where GreA could, for example, enhance gene expression of a greA repressor. At the same time, indirect regulation would require the existence of a binding site for such a repressor-in this case, perhaps the GraL sequence could serve as such a site, since it is essential for autoregulation to occur (Figure 3d ). However, scrambling of the GraL sequence does not alleviate GreA repression (Figure 6c ), and can be seen as evidence against the indirect model. On the other hand, the same arguments can be made in case of the direct model-requirement for GreA antipause activity and specific sequence binding cannot be excluded. Certainly, further studies are required to clarify the exact regulatory mechanism.
As already mentioned, it has been suggested that the efficiency of termination at the sRNA intrinsic terminators is regulated by the same signals (physiological or occurring at times of stress) that induce transcriptional initiation of a given sRNA [29] . This seems not to be true for GreA since here it does not affect the transcription initiation step. However, we wondered whether σ E could be the auxiliary factor enhancing GreA's activity, since σ E controls transcription initiation from the pgreA P2 promoter. Although we did observe a moderate increase in transcriptional activity of the pgreA all -lacZ fusion in vivo when σ E activity was induced by accumulation of misfolded proteins (GreA level was kept constant here), the activity of the other fusions did not increase when the promoter region was replaced with plac UV5 . Besides confirming that our basic fusion construct is responsive to σ E , this also implies that the auxiliary factor necessary for GreA autoregulation is not under σ E control. We believe that Hfq and the Nus factors are also excluded as the possible accessory factors to GreA. Further studies, perhaps employing transposon random libraries or plasmid libraries of overexpressed genes, are needed to identify the additional factor necessary for GreA autoregulation to occur. Another approach could involve a random point mutant screen for greA leader isolates that block in vivo autoregulation, which could then be used in a pulldown search for a protein that binds to normal greA leader sequences but not to the autoregulation inefficient mutant. Additionally, another future approach could include investigating a possible role of Rho in this process. Although GraL is very short (only 19 nts before the terminator structure is formed) and terminates at a Rho-independent terminator, it cannot be excluded that the GraL sequence and structure may provide a conditional binding site for Rho, which together with GreA might enhance termination.
How has the GreA/GraL system developed? It seems more plausible that GreA autoregulation (GraL acting in cis) had evolved first, and GraL acting in trans arose as a secondary function. It should be noted that regulation by early transcriptional termination at the 5 UTR is a common mechanism among bacteria, where attenuators, riboswitches, or T-boxes are employed [36] . All of these mechanisms often rely on alternative RNA secondary structures that under certain conditions may form an intrinsic terminator.
Attempting to qualify GraL as an attenuator or a riboswitch is a complex issue. For one thing, our data show that some remnant GreA autoregulation still persists when either the sequence upstream of the terminator or the terminator hairpin sequence is scrambled, pointing to a slight degree of sequence identity independence. On the other hand, even though termination read-through was enhanced in vivo, termination was still observed when using these fusions as templates in in vitro transcription. This indicates that the β-galactosidase activities observed in vivo did reflect a change in response to the unknown accessory factor, or to GreA and the factor acting together, and did not merely result from abolished termination per se.
On the basis of classic attenuators, one would expect the effector to counteract or alleviate the "normal" (physiological) course of events, i.e., induce terminator formation if usually not formed, or prevent its formation if usually formed. In the case of GreA and GraL, this is not so-GreA (directly or indirectly) seems to amplify termination at the GraL terminator instead of abolishing it. Similar conundrums are encountered when thinking of GraL in terms of a riboswitch-the accessory molecule, acting jointly with GreA, should abolish termination, not enhance it. Of course, it cannot be excluded that under certain conditions GraL termination is overridden-such conditions remain yet to be found. It is also possible that GraL may act as an attenuator or riboswitch under a certain set of conditions, while GreA autoregulation forms a separate or possibly intertwining regulatory circuit.
In the simplest terms, the GreA/GraL system represents a feedback regulatory loop with many unique features. The greA expression is controlled by the GreA protein itself (through GraL acting in cis), but this system also widens GreA's regulatory web (through GraL acting in trans). Definitely, many questions still remain and future studies are needed to dissect the precise mechanism governing greA expression. Our study is an example of how complex and intricate systems are in place to regulate and fine-tune the expression of a global regulator (in this case, a very important transcriptional factor). In addition, the results presented here may aid in the discovery of similar systems, which nevertheless may possess unique variations of their own.
Materials and Methods
Strains and Plasmids
All transcriptional fusions with lacZ were constructed by introducing an appropriate DNA fragment (obtained either by PCR or through a GeneArt (GeneStrings) service from ThermoFisher Scientific, Waltham, MA, USA) into a pRS415 plasmid (restriction sites: BamHI/EcoRI) [37] , except for the greA −1030 to +175 lacZ fusion, which was constructed by cloning the DNA fragment obtained by PCR (primers G1 and G7) into pRS515 plasmid [37] . Thus, the obtained multicopy fusions were introduced as a single copy on the E. coli chromosome with the use of phage λRS45 and verified to be monolysogens by PCR [38] .
For GraL overproduction, pGraL plasmid was constructed by annealing MDGLUP and MDGLDWN primers to each other, followed by 1 cycle of extension by Taq polymerase (GoTaq, Promega, Madison, WI, USA) and subsequent dsDNA purification on Amicon Ultra 0.5 mL device (10 kD cut-off; Merck, Germany); this fragment was then digested with EcoRI/HindIII and cloned into a pGB2 vector derivative cut with the same enzymes. For GreA overproduction, pHM1873 plasmid (pGreA) was used, and pHM1883 was used as control (pV) [18] . For Nus factor overproduction, pNusA, pNusB, pNusE, and pNusG plasmids were used [39] , with pHM1883 as control. For σ E induction, pBAI66 was used, with pTrc99 as control [30, 40] . For Hfq overproduction, F+hfq was used, with F+rpoB as control [41] . For the construction of pBR-GreA and pBR-GreA D41A, both alleles were amplified together with their native promoters (using G1 and G11 primers) from MG1655 [42] and TP1204 [43] , respectively, and cloned into pBR322 [44] using EcoRI and PstI restriction sites. Gene deletions/modifications were introduced by standard P1 transduction [45] . Strain JW4130-1 was used as a source of ∆hfq-722:kan [46] . All strains and plasmids used are listed in Table S6 and  Table S7 , respectively. The oligonucleotides and synthetic DNA fragments used are listed in Table  S8 . All oligonucleotides were ordered from Sigma/Merck (Darmstadt, Germany), and all restriction enzymes were purchased from ThermoFisher Scientific (Waltham, MA, USA).
